Overview
RCEL market data
Price History
RCEL price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.74 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.83 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.22 – $7.12 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $141.9 · P/B 74.59 · P/S 1.96.
Company News
Why Celestica Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 28, 2026, 9:01 AM
Why ServiceNow Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 23, 2026, 8:35 AM
Lake Street Upgrades AVITA Medical to Buy, Raises Price Target to $6Benzinga · May 15, 2026, 5:44 PM
AVITA Medical Reports Q1 2026 Results: Full Earnings Call TranscriptBenzinga · May 14, 2026, 9:26 PM
AVITA Medical Affirms FY2026 Sales Guidance of $80.000M-$85.000M vs $82.258M EstBenzinga · May 14, 2026, 8:07 PM
AVITA Medical Q1 EPS $(0.35) Misses $(0.28) Estimate, Sales $19.251M Beat $18.175M EstimateBenzinga · May 14, 2026, 8:06 PM
Earnings Scheduled For May 14, 2026Benzinga · May 14, 2026, 11:11 AM